Melanophilin (Mlph) forms an interaction with Rab27a and the actinbased motor protein MyosinVa (MyoVa) on mature melanosome membranes and the tripartite complex regulates melanosome transport in melanocytes. In this study, we found that Rab27a siRNA decreased Mlph and Rab27a protein levels, but Mlph mRNA levels were not changed. Other Rab27a siRNA sequences also showed the same results. When Rab27a siRNA was treated with melan-a melanocytes, Rab27a protein was decreased within 6 hours and Mlph protein was decreased within 24 hours. To determine whether the absence of Rab27a promotes Mlph degradation, we inhibited protein degradation by treatment with proteasome (MG132) and lysosomal enzyme (E64D and Pepstatin A) inhibitors in melan-a melanocytes. MG132 inhibited the degradation of Mlph, but E64D and Pepstatin A had no effect on Mlph. The absence of Rab27a enhanced ubiquitination of Mlph and induced proteasomal degradation. From these results, we concluded that Mlph interaction with Rab27a is important for Mlph stability and melanosome transport.
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| BACKG ROU N D
Melanosomes are specific melanin-containing pigment granules of epidermal melanocytes that synthesize and store melanin. [1] Melanosomes mature in four stages with characteristic morphological changes. After melanosomes fully mature, they are transported along microtubules to the peripheral region where they are captured in the cortical actin network before they are transferred to adjacent keratinocytes.
[2] Evans et al. indicated that MyosinVa (MyoVa) and actin are another main drivers of melanosome dispersion in murine melanocytes. [3] In melanosome transport, there are three key player proteins.
Rab27a, melanophilin (Mlph) or slac2-a and MyoVa that form a tripartite complex that allows interaction of melanosomes with the actin network. [4, 5] Rab27a is a small GTPase present on the membrane of mature melanosomes that is involved in intracellular vesicular transport and organelle dynamics. [6] Mlph is the effector of Rab27a that interacts directly with the GTP-bound form of Rab27a and MyoVa. [7] MyoVa performs the role of melanosome trafficking in melanocytes. [8] However, depletion of any one of the components of the tripartite complex causes perinuclear aggregation of melanosomes because of the defect in melanosome transport from the perinuclear space to dendrite tips. [9] According to a recent study, Rab27a-Mlph and Mlph-MyoVa interactions are very important for melanosome transport. For example,
Hesperidin blocks the Rab27a-Mlph interaction in silico and causes melanosome aggregation in melanocytes. [10] Also, Manassantin B causes melanosome aggregation in melanocytes by blocking MlphMyoVa interaction. [11] In the previous studies, Mlph protein level is decreased in ashen (Rab27a −/−) melanocytes and siRNA depletion of Rab27a melan-a melanocytes. [12, 13] Stronger evidence is found by Mlph R35W mutant protein from Griscelli syndrome (GS) type 3 patient. Mlph R35W mutant protein completely impairs Rab27a-Mlph interaction and causes inhibition of melanosome transport. [14] From these studies, we know that melanosome transport could be influenced by inhibiting interaction of the tripartite complex as well as the loss of any one of the components of the tripartite complex.
| QUE S TIONS ADDRE SS ED
In this study, we found that reduced Rab27a expression by siRNA treatment can affect Mlph protein level. But, the MyoVa expression was not influenced by reduced Rab27a level by siRNA treatment.
However, the relationship between Rab27a and Mlph has not been reported. Therefore, we investigated the interaction of Rab27a and
Mlph to elucidate the effect of protein stabilization between them.
| E XPERIMENTAL DE S I G N
Materials and Methods are detailed in Appendix S1.
| RE SULTS
When we treated melan-a melanocytes with Rab27a, Mlph and MyoVa siRNA, melanosomes were shown to cluster in the perinuclear region ( Figure S1 ) and Rab27a, Mlph and MyoVa expression were reduced, respectively, at 72 hours ( Figure 1A ). Interestingly, treatment with Rab27a siRNA decreased Mlph protein level in addition to Rab27a levels. To determine whether Rab27a siRNA had an effect on
Mlph non-specifically, we tested different Rab27a siRNA sequences 
| CON CLUS IONS
In this study, when melan-a melanocytes were treated with Rab27a siRNA, Rab27a and Mlph protein levels were decreased; however, the mRNA level of Mlph was not decreased after Rab27a siRNA treatment.
Other two additional different Rab27a siRNA sequences showed similar results.
Rab proteins belong to a family of small GTPases and cycle between the inactive GDP-bound form and an active GTP-bound form. In the active GTP-bound form, Rab proteins recruit effectors that control membrane trafficking. [15] This exchange reaction is stimulated by the interaction of Rab proteins with one of a family of regulatory proteins referred to as guanine nucleotide exchange factors or GEFs. [16] According to a recent study, Rab3GEP is a protein that functions with non-redundant Rab27 GEF activity in melanocytes. [17] They noted that Rab3GEP siRNA results in the perinuclear aggregation of melanosomes and decreased Mlph protein levels. In another study, Rab27a was found on mature melanosome membranes in Rab3GEP-depleted melanocytes. [18] These studies show that the depletion of Rab3GEP does not change the amount of Rab27a protein. However, the Rab27a-GDP inactive F I G U R E 1 Western blotting and qRT-PCR analysis of Rab27a, Mlph and MyoVa by siRNA in melan-a melanocytes. A, Rab27a, Mlph and MyoVa protein levels were measured after treatment with Rab27a, Mlph and MyoVa siRNA and scrambled siRNA. B, Rab27a #1 and Rab27a #2 siRNA in melan-a melanocytes for 72 h. PBS was used negative control. Values are the mean value of expression normalized to that of β-actin from three independent experiments ± SD. **P < 0.01, ***P < 0.001 compared with control. C, Levels of Mlph, Rab27a and MyoVa mRNA were measured after treatment with Rab27a siRNA in melan-a melanocytes for 48 h. Values are the mean value of expression normalized to β-actin and relative to control from three independent experiments ± SD. Data were analysed using Student's unpaired t test. ***P < 0.005 Figure S2 . qRT-PCR results of Rab27a, Mlph and MyoVa using different Rab27a siRNAs in melan-a melanocytes. Mlph, Rab27a and MyoVa mRNA levels were measured after treatment with Rab27a siRNA #1 and #2 for 48 hours. Values are the mean value of expression normalized to β-actin and relative to control from three independent experiments ± SD. Data were analysed using Student's unpaired t tests. *P < 0.05, **P < 0.01, ***P < 0.005. Data were analysed using Student's unpaired t tests. **P < 0.01, ***P < 0.005 compared with control; † P < 0.05 compared with ∆ 42 hours control-42 hours siRab27a.
